[1]
|
Assessment of Quality of Life 8-Dimension (AQoL-8D): translation, validation, and application in two Dutch trials in patients with epilepsy and schizophrenia
Expert Review of Pharmacoeconomics & Outcomes Research,
2022
DOI:10.1080/14737167.2021.1981861
|
|
|
[2]
|
Patient‐reported impact of symptoms in schizophrenia scale (PRISS): Development and validation
Acta Psychiatrica Scandinavica,
2022
DOI:10.1111/acps.13417
|
|
|
[3]
|
Construct and criterion validity of patient-reported outcomes (PROs) for depression: A clinimetric comparison
Journal of Affective Disorders,
2021
DOI:10.1016/j.jad.2021.01.043
|
|
|
[4]
|
A Methodological Review of Quality of Life Scales Used in Schizophrenia
Journal of Nursing Measurement,
2021
DOI:10.1891/JNM-D-18-00053
|
|
|
[5]
|
Construct and criterion validity of patient-reported outcomes (PROs) for depression: A clinimetric comparison
Journal of Affective Disorders,
2021
DOI:10.1016/j.jad.2021.01.043
|
|
|
[6]
|
Relapse Risk Assessment for Schizophrenia Patients (RASP): A New Self-Report Screening Tool
Clinical Schizophrenia & Related Psychoses,
2018
DOI:10.3371/CSRP.DVWC.111717
|
|
|
[7]
|
Patientenberichtete Lebensqualität in der klinischen Forschung und Arzneimittelbewertung
Forum,
2018
DOI:10.1007/s12312-018-0387-2
|
|
|
[8]
|
Health related quality of life in patients having schizophrenia negative symptoms – a systematic review
Journal of Market Access & Health Policy,
2018
DOI:10.1080/20016689.2018.1517573
|
|
|
[9]
|
Generic and disease-specific quality of life and its predictors among Chinese inpatients with schizophrenia
Psychiatry Research,
2015
DOI:10.1016/j.psychres.2015.05.033
|
|
|